Loading company
Lexaria Bioscience Corp.
LEXX · Nasdaq · ·
$3.02-6.4%Sep 29 close
- 1M
- -70.8%
- 6M
- -74.2%
- 1Y
- -78.9%
- 5Y
- -96.8%
LEXX · Nasdaq · ·
$3.02-6.4%Sep 29 close
The quarter ending May 31, 2026, against the same quarter a year earlier.
| Measure | 3 months toMay 31, 2026 | 3 months toMay 31, 2025 | Change |
|---|---|---|---|
| Total Revenue | $0.00 | $174K | -100.00% |
| Profit | -$2M | -$3.8M | +47.45% |
| Profit per share | -$0.08 | -$0.21 | +61.90% |
| Free Cash Flow | -$1.6M | -$3.6M | +54.38% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Lexaria Bioscience Corp. has no earnings call transcript available.